nanoparticles Search Results


titanium dioxide  (Nanografi Advanced Materials)
93
Nanografi Advanced Materials titanium dioxide
Titanium Dioxide, supplied by Nanografi Advanced Materials, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/titanium dioxide/product/Nanografi Advanced Materials
Average 93 stars, based on 1 article reviews
titanium dioxide - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
liquid chromatography  (KCAS Bioanalytical and Biomarker Services)
93
KCAS Bioanalytical and Biomarker Services liquid chromatography
Liquid Chromatography, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/liquid chromatography/product/KCAS Bioanalytical and Biomarker Services
Average 93 stars, based on 1 article reviews
liquid chromatography - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
lipid nanoparticle  (Dicerna Inc)
86
Dicerna Inc lipid nanoparticle
Chronological <t>nanoparticle</t> approvals based on particle type
Lipid Nanoparticle, supplied by Dicerna Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lipid nanoparticle/product/Dicerna Inc
Average 86 stars, based on 1 article reviews
lipid nanoparticle - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier
goat anti mouse igg abs  (Rockland Immunochemicals)
93
Rockland Immunochemicals goat anti mouse igg abs
Chronological <t>nanoparticle</t> approvals based on particle type
Goat Anti Mouse Igg Abs, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti mouse igg abs/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
goat anti mouse igg abs - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
cellulose nanocrystals  (Nanografi Advanced Materials)
94
Nanografi Advanced Materials cellulose nanocrystals
Chronological <t>nanoparticle</t> approvals based on particle type
Cellulose Nanocrystals, supplied by Nanografi Advanced Materials, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cellulose nanocrystals/product/Nanografi Advanced Materials
Average 94 stars, based on 1 article reviews
cellulose nanocrystals - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
nano silver powder  (Nanografi Advanced Materials)
93
Nanografi Advanced Materials nano silver powder
Chronological <t>nanoparticle</t> approvals based on particle type
Nano Silver Powder, supplied by Nanografi Advanced Materials, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nano silver powder/product/Nanografi Advanced Materials
Average 93 stars, based on 1 article reviews
nano silver powder - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
carbon black  (Nanografi Advanced Materials)
93
Nanografi Advanced Materials carbon black
Chronological <t>nanoparticle</t> approvals based on particle type
Carbon Black, supplied by Nanografi Advanced Materials, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/carbon black/product/Nanografi Advanced Materials
Average 93 stars, based on 1 article reviews
carbon black - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
nanoparticle dispersions  (Eppendorf AG)
99
Eppendorf AG nanoparticle dispersions
Chronological <t>nanoparticle</t> approvals based on particle type
Nanoparticle Dispersions, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nanoparticle dispersions/product/Eppendorf AG
Average 99 stars, based on 1 article reviews
nanoparticle dispersions - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
cnc certified reference material  (National Research Council Canada)
90
National Research Council Canada cnc certified reference material
Chronological <t>nanoparticle</t> approvals based on particle type
Cnc Certified Reference Material, supplied by National Research Council Canada, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cnc certified reference material/product/National Research Council Canada
Average 90 stars, based on 1 article reviews
cnc certified reference material - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
nano sized zinc oxide powders zno  (Nanografi Advanced Materials)
93
Nanografi Advanced Materials nano sized zinc oxide powders zno
Chronological <t>nanoparticle</t> approvals based on particle type
Nano Sized Zinc Oxide Powders Zno, supplied by Nanografi Advanced Materials, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nano sized zinc oxide powders zno/product/Nanografi Advanced Materials
Average 93 stars, based on 1 article reviews
nano sized zinc oxide powders zno - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
spherical aluminium oxide al2o3 nano powder nano particle  (Nanografi Advanced Materials)
93
Nanografi Advanced Materials spherical aluminium oxide al2o3 nano powder nano particle
Chronological <t>nanoparticle</t> approvals based on particle type
Spherical Aluminium Oxide Al2o3 Nano Powder Nano Particle, supplied by Nanografi Advanced Materials, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spherical aluminium oxide al2o3 nano powder nano particle/product/Nanografi Advanced Materials
Average 93 stars, based on 1 article reviews
spherical aluminium oxide al2o3 nano powder nano particle - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
hydroxyapatite  (Nanografi Advanced Materials)
93
Nanografi Advanced Materials hydroxyapatite
Chronological <t>nanoparticle</t> approvals based on particle type
Hydroxyapatite, supplied by Nanografi Advanced Materials, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hydroxyapatite/product/Nanografi Advanced Materials
Average 93 stars, based on 1 article reviews
hydroxyapatite - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Chronological nanoparticle approvals based on particle type

Journal: Bioengineering & Translational Medicine

Article Title: Nanoparticles in the clinic: An update post COVID ‐19 vaccines

doi: 10.1002/btm2.10246

Figure Lengend Snippet: Chronological nanoparticle approvals based on particle type

Article Snippet: DCR‐MYC (Dicerna Pharmaceuticals) , Lipid nanoparticle , DsiRNA for NYC oncogene silencing , Solid tumors, multiple myeloma, lymphoma, or hepatocellular carcinoma , 2016: NCT02110563 (Ph I): Terminated (Sponsor Decision) NCT02314052 (Ph I/II) Terminated (Sponsor Decision) , 2021: Results posted and viewable on ClinicalTrials.gov for NCT02314052 2019: Zero new trials Two trials updated to terminated.

Techniques:

Chronological nanoparticle approvals based on indication

Journal: Bioengineering & Translational Medicine

Article Title: Nanoparticles in the clinic: An update post COVID ‐19 vaccines

doi: 10.1002/btm2.10246

Figure Lengend Snippet: Chronological nanoparticle approvals based on indication

Article Snippet: DCR‐MYC (Dicerna Pharmaceuticals) , Lipid nanoparticle , DsiRNA for NYC oncogene silencing , Solid tumors, multiple myeloma, lymphoma, or hepatocellular carcinoma , 2016: NCT02110563 (Ph I): Terminated (Sponsor Decision) NCT02314052 (Ph I/II) Terminated (Sponsor Decision) , 2021: Results posted and viewable on ClinicalTrials.gov for NCT02314052 2019: Zero new trials Two trials updated to terminated.

Techniques:

Clinically approved nanoparticle therapies and diagnostics, grouped by their broad indication

Journal: Bioengineering & Translational Medicine

Article Title: Nanoparticles in the clinic: An update post COVID ‐19 vaccines

doi: 10.1002/btm2.10246

Figure Lengend Snippet: Clinically approved nanoparticle therapies and diagnostics, grouped by their broad indication

Article Snippet: DCR‐MYC (Dicerna Pharmaceuticals) , Lipid nanoparticle , DsiRNA for NYC oncogene silencing , Solid tumors, multiple myeloma, lymphoma, or hepatocellular carcinoma , 2016: NCT02110563 (Ph I): Terminated (Sponsor Decision) NCT02314052 (Ph I/II) Terminated (Sponsor Decision) , 2021: Results posted and viewable on ClinicalTrials.gov for NCT02314052 2019: Zero new trials Two trials updated to terminated.

Techniques: Imaging

Chronological update on the number of clinical trials for each nanoparticle, based on the number of identified trials in our previous “Nanoparticles in the Clinic” reviews in 2016 and 2019. These trials and nanoparticles have appeared on the ClinicalTrial.gov database Source : Modified with permissions from References and

Journal: Bioengineering & Translational Medicine

Article Title: Nanoparticles in the clinic: An update post COVID ‐19 vaccines

doi: 10.1002/btm2.10246

Figure Lengend Snippet: Chronological update on the number of clinical trials for each nanoparticle, based on the number of identified trials in our previous “Nanoparticles in the Clinic” reviews in 2016 and 2019. These trials and nanoparticles have appeared on the ClinicalTrial.gov database Source : Modified with permissions from References and

Article Snippet: DCR‐MYC (Dicerna Pharmaceuticals) , Lipid nanoparticle , DsiRNA for NYC oncogene silencing , Solid tumors, multiple myeloma, lymphoma, or hepatocellular carcinoma , 2016: NCT02110563 (Ph I): Terminated (Sponsor Decision) NCT02314052 (Ph I/II) Terminated (Sponsor Decision) , 2021: Results posted and viewable on ClinicalTrials.gov for NCT02314052 2019: Zero new trials Two trials updated to terminated.

Techniques: Modification

Updates on previously reported nanoparticle clinical trials that are not clinically approved or authorized and are currently active in clinical trials

Journal: Bioengineering & Translational Medicine

Article Title: Nanoparticles in the clinic: An update post COVID ‐19 vaccines

doi: 10.1002/btm2.10246

Figure Lengend Snippet: Updates on previously reported nanoparticle clinical trials that are not clinically approved or authorized and are currently active in clinical trials

Article Snippet: DCR‐MYC (Dicerna Pharmaceuticals) , Lipid nanoparticle , DsiRNA for NYC oncogene silencing , Solid tumors, multiple myeloma, lymphoma, or hepatocellular carcinoma , 2016: NCT02110563 (Ph I): Terminated (Sponsor Decision) NCT02314052 (Ph I/II) Terminated (Sponsor Decision) , 2021: Results posted and viewable on ClinicalTrials.gov for NCT02314052 2019: Zero new trials Two trials updated to terminated.

Techniques: Radioactivity, Plasmid Preparation, Sequencing, Derivative Assay, Neutralization, Imaging, Infection, Activity Assay

Nanoparticle vaccines, therapies, and diagnostics which are not clinically approved and are currently active clinical trials that have appeared on the ClinicalTrial.gov database since 2019

Journal: Bioengineering & Translational Medicine

Article Title: Nanoparticles in the clinic: An update post COVID ‐19 vaccines

doi: 10.1002/btm2.10246

Figure Lengend Snippet: Nanoparticle vaccines, therapies, and diagnostics which are not clinically approved and are currently active clinical trials that have appeared on the ClinicalTrial.gov database since 2019

Article Snippet: DCR‐MYC (Dicerna Pharmaceuticals) , Lipid nanoparticle , DsiRNA for NYC oncogene silencing , Solid tumors, multiple myeloma, lymphoma, or hepatocellular carcinoma , 2016: NCT02110563 (Ph I): Terminated (Sponsor Decision) NCT02314052 (Ph I/II) Terminated (Sponsor Decision) , 2021: Results posted and viewable on ClinicalTrials.gov for NCT02314052 2019: Zero new trials Two trials updated to terminated.

Techniques: Expressing, CRISPR, Knock-Out, Recombinant, Cell Culture